Effectiveness of Rebif® in Clinically Isolated Syndrome and Relapsing Multiple Sclerosis Using RebiSmart™

NCT02254304 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

106

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsing Multiple Sclerosis
Clinically Isolated Syndrome

Interventions

DRUG: Rebif

Sponsor

Merck KGaA, Darmstadt, Germany

Collaborators

[object Object]